Latest Market Outlook News

AMCIL Limited reported a 14.8% increase in half-year profit to $4.1 million, maintaining its interim dividend amid a portfolio return that lagged the ASX 200 benchmark.

Gold Mountain Limited has agreed to sell its Papua New Guinea exploration licences for $2 million, redirecting funds to advance its promising Brazilian projects and strengthen working capital.

Compumedics has delivered record first-half sales orders and a 32% jump in shipped revenue, setting the stage for a robust second half driven by new product launches and operational efficiencies.

Deep Yellow Limited reports strong progress on its flagship Tumas Project with key engineering milestones and exploration successes, while preparing for a leadership transition and navigating a buoyant uranium market.

Australian Foundation Investment Company reports a 4.6% decline in half-year profit but sustains its interim dividend with a special payout, while portfolio returns lag the benchmark.

Rivco Australia Limited has completed its internalisation, reporting a modest decline in net asset value alongside rising water spot prices and a strong dividend yield, signaling evolving dynamics in the water entitlements market.

Paladin Energy reports a strong production ramp-up at its Langer Heinrich Mine and confirms robust progress on the Patterson Lake South project, supported by a strengthened balance sheet and a positive uranium market outlook.

LinQ Minerals reports consistent high-grade gold and copper mineralisation over a 300m strike at its Dam deposit, with further drilling planned to expand the resource.

4DMedical Limited has raised AU$150 million to accelerate the commercial rollout of its FDA-cleared CT, VQ lung imaging technology in the US, leveraging a strategic partnership with Philips. This funding aims to expand adoption across major medical centres and government healthcare programs.

Navigator Global Investments reported steady ownership-adjusted assets under management of USD29 billion for the December 2025 quarter, buoyed by strong hedge fund performance and resilient private markets growth despite the Bardin Hill sale.

Mirrabooka Investments reported a 93.6% jump in half-year profit to $8.9 million, maintaining its fully franked dividend despite portfolio returns trailing the small and mid-cap benchmark.

ReNerve Limited has secured market approval for its NervAlign® Nerve Cuff in Malaysia, marking a key milestone in its Asia-Pacific expansion strategy. This approval follows earlier clearances in Hong Kong and Thailand, positioning the company to tap into a growing regional nerve repair market.